Goldplay Discovers New High-grade Mineralization At San Marcial and Confirms Upside Resource Potential.


1.5 meters (true width 1.5 meters) @ 1,197 gpt Ag or 1,285 gpt AgEq*


1.5 meters (true width 1.5 meters) @ 1,197 gpt Ag or 1,285 gpt AgEq*

FSD Pharma Inc. (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) (“FSD Pharma” or the “Company), which, through its wholly-owned subsidiary FV Pharma Inc., is a licensed producer pursuant to the Access to Cannabis for Medical Purposes Regulations, is pleased to announce that it has signed a definitive collaboration and profit sharing agreement (the “Agreement“) with Canntab Therapeutics Limited (CSE:PILL) (“Canntab“), a leader in the rapidly growing cannabis pill market, effective September 17, 2018. Under the terms of the Agreement, FSD Pharma will assist Canntab to obtain a license to process and sell cannabis products pursuant to the Cannabis Act (the “License“), and will provide Canntab with space at its facility (the “FSD Facility“), which is located just one hour east of Toronto in Cobourg, Ontario (the “Transaction“).
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company“) is pleased to announce that it has reached agreement to acquire a 100% interest in a portfolio of mining claims comprising the Henderson, Flow/Work Creek and Birdman properties (collectively, the “Properties”) from Independence Gold Corp. (TSX.V: IGO) (“IGO”) in exchange for an aggregate cash payment of $35,000, 160,000 common shares in the capital of the Company (the “Shares”), and two 1% net smelter return (“NSR”) royalties on the Properties. The Properties are comprised of an aggregate of 920 claims representing approximately 18,000 hectares of land in the White Gold District. The Company has also staked 299 claims adjacent to the JP Ross and Hen properties (the “Staked Claims”). The acquisitions extend the Company’s land package immediately to the west and south of the Company’s JP Ross property in the area surrounding the recently announced discovery and increases the Company’s landholdings in the Yukon to 409,000 hectares. Maps further detailing the property locations can be found at http://whitegoldcorp.ca/investors/exploration-highlights/.

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) today announced that it has joined the Cannabis Marketing Resource Center (“CMRC”) provided by Snipp Interactive Inc. (“Snipp”) (OTCQB: SNIPF; TSX-V: SPN), a global provider of digital marketing promotions, rebates and loyalty solutions. FSD has now joined some of the largest licensed producers in Canada that currently use the CMRC and the technology solutions provided by Snipp.

MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / OTCQB: MGXMF / FSE: 1MG) is pleased report that the Company’s local Operating Partner (the “Partner”) has received approval from the U.S. Bureau of Land Management (“BLM”) to complete a 65.4 square mile 3D seismic survey over the Blueberry Unit (“Blueberry”) at the Company’s Utah Petrolithium Project (the “Project”) located in the Paradox Basin of Utah. The survey will include 9,062 source points and comprise 6,354 vibrator points, 841 buggy drill points and 1,867 Heli points. The Company plans to commence the 3D Seismic Survey shortly.
White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the “Company”) is pleased to announce initial drill results from the Vertigo target on the JP Ross property, Yukon. The Rotary-Air-Blast (“RAB”) drilling followed up on high-grade GT Probe results on the property announced on August 14, 2018. Results received to date include the first 10 of 17 RAB holes, with the balance expected in the near future. A Reverse Circulation (“RC”) drill is currently on site to further test the Vertigo target. Maps further detailing hole locations and results can be found at http://whitegoldcorp.ca/investors/exploration-highlights/.

On September 10 Bayhorse Silver Inc (TSXV: BHS) reported the first set of assays (BHS2018-28) on our channel sampling program at the Bayhorse Silver Mine in Oregon.

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9) is pleased to announce that it intends to launch a strategic partnership into the Jamaican cannabis market as part of its plan to expand internationally. FSD has signed a Letter of Intent (“LOI”) effective September 10, 2018 with JJAMACANN Inc. (“JJAMACANN”) to form a joint venture operating as FSD Jamaica (“FSD Jamaica”). FSD Jamaica expects to partner locally with Nature’s Purest Limited (“NPL”), a Jamaican corporation with a cultivation license and existing operations in Jamaica.

FSD Pharma Inc. (“FSD” or the “Company”) (CSE: HUGE) (OTC: FSDDF) (FRA: 0K9), is pleased to report that on September 11, 2018 the Company traded an aggregate total of exactly 213,761,823 shares. FSD traded 143,260,988 Class B subordinate voting shares on the Canadian Securities Exchange (“CSE”), 1,888,500 on AQC-Lit, 15,369,000 on AQC-Neo, 241,740 on CXC, 5,309,399 on CX2, 6,473,592 on CXD, 22,500 on Lynx, 24,750,500 on Omega and 16,445,604 on MatchNow. This is the largest total quantity of share volume traded by a CSE listed issuer by over 15.7% above the recorded all-time high of 184,718,114 also achieved by FSD on September 10, 2018, as confirmed by the CSE. This record is also 41% over the Company’s previous reporting of achieving an all-time high of 151,183,895 on September 4, 2018.

Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L), is pleased to provide an update regarding the Company’s rapid progress in developing and building a large-scale Pilot Plant for deployment at the Arkansas project site. The Company and its Scientific Advisory Team have been developing, testing and optimising proprietary lithium extraction and crystallisation technologies on Smackover brines for over a year, and are now at the stage where the process flowsheet is sufficiently tested and proven to allow procurement and fabrication to commence on the full-scale Pilot Plant.